In this session, panelists from pharma and healthcare share perspectives on innovations in decentralized clinical trial technologies that have and have not worked during and throughout COVID. They also discuss:

How we are bringing forth trial options to people on their own terms and getting patient input
Creating flexible systems that don’t increase undue burden on hospitals and sites
What hasn’t worked and why
Managing cost and spend

Speakers:

Sharon Hanlon, Head, Clinical Trial Engagement & Enrolment, Bristol Myers Squibb
Christina Brennan, MD, MBA, VP, Clinical Research, Northwell Health
Jamie Harper, MHA, CCRP, Director, Site Engagement & Relations, WCG Clinical
Ramita Tandon, Chief Clinical Trials Officer, Walgreens Health, Walgreens Boots Alliance
Susan Wong, PA, Principal Quality & Compliance Manager, gRED, Genentech

Where and How DCTs Can Truly Enable and Close the Gaps between Research and Care

Share

Embed